08/30/2012 - 2:07pm

The Food and Drug Administration has approved a new drug for treating bowel diseases made by Ironwood Pharmaceuticals, the agency said Thursday.

08/30/2012 - 12:58pm

Drug maker Eli Lilly has partnered with nationally recognized health literacy experts to implement new standards to ensure the company's patient communications and resources adhere to health literacy principles.

08/30/2012 - 11:12am

Eli Lilly announced that Michael Harrington will be promoted to SVP and general counsel, effective Jan. 1, 2013.

08/30/2012 - 10:42am

The National Council on Aging last week introduced a new national Flu + You campaign to improve vaccination rates among seniors.

08/29/2012 - 1:06pm

A panel of outside advisers to the Food and Drug Administration has backed wider use for Abbott Labs’ rheumatoid arthritis drug, Humira, for treating a type of inflammatory bowel disease.

08/29/2012 - 12:44pm

The Food and Drug Administration has granted priority review to a supplemental new drug application for a drug developed by Janssen Research and Development.

08/29/2012 - 10:02am

The Food and Drug Administration has approved a supplemental new drug application for an opioid analgesic to treat diabetes-related pain.

08/29/2012 - 9:52am

Eli Lilly has ceased ongoing clinical studies of an investigational treatment for schizophrenia.

08/28/2012 - 7:44pm

While the growth in healthcare costs remains a threat in the United States, the growth in drug expenditures is moderating, but numerous opportunities exist for retail, according to a speech delivered Tuesday morning at the National Association of Chain Drug Stores' 2012 Pharmacy and Technology Conference in Denver by Doug Long, VP industry relations of healthcare industry research firm IMS Health.